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SUMMARY
A literature search traced existing information on meningococcal disease in Asia. Reviewed
data describing the epidemiology of meningococcal disease in Asia are incomplete, due in part to
absence of surveillance in many countries, poor bacterial detection methods and social and
healthcare barriers to disease reporting. This suggests that meningococcal disease in some Asian
countries may be under-recognized, with a need to introduce/improve existing surveillance and
case identiﬁcation systems. Nevertheless, in some developing Asian countries, the disease burden
may be signiﬁcant. Serogroup A meningococcal epidemics are responsible for high morbidity and
mortality in some countries and continue to be an ongoing threat, particularly in developing
countries. There is an increasing role played by serogroups C, Y, and W-135 in invasive disease,
indicating evolving meningococcal disease epidemiology in some countries. Multivalent
meningococcal conjugate vaccines oﬀer new opportunities in the region for reducing the
meningococcal disease burden.
Key words: Asia, epidemic, epidemiology, meningococcal meningitis, meningococcal infection,
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INTRODUCTION
Despite appropriate antibiotic and supportive ther-
apy, invasive disease due to Neisseria meningitidis re-
sults in death in around 10% of cases. Higher
mortality rates are often observed in developing
countries and during epidemics [1]. The majority of
invasive meningococcal disease globally is caused by
N. meningitidis serogroups A, B, C, W-135, and Y.
Serogroup C and combined serogroups A, C, W-135,
and Y (ACWY) conjugate vaccines are now avail-
able. Better understanding of the burden of menin-
gococcal disease in individual countries will guide
next-generation vaccine development and allow accu-
rate assessment of the potential impact of such vac-
cines if introduced into vaccination calendars. This
information will assist health policy-makers and
healthcare professionals in allocating healthcare re-
sources to maximize medical beneﬁt to the popu-
lation.
More than one-half of the world’s population re-
sides in Asia [2], a region characterized by densely
populated countries and socioeconomic, geographic
and ethnic diversity. The epidemiology of meningo-
coccal disease in much of Asia is incompletely under-
stood, but is likely to be diverse [3]. N. meningitidis
serogroup A and C outbreaks are occasionally re-
ported to the World Health Organization (WHO)
Regional Oﬃce in Asia, or to national authorities.
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ber of meningococcal cases may be misdiagnosed or
under-reported. This review examined the available
published literature and national infectious disease
surveillance websites or reports where available. The
aims of the review were to collate and summarize any
existing information on the epidemiology of disease
due to N. meningitidis in Asia, including GAVI
(Global Alliance for Vaccines and Immunization)-
eligible countries in the region, and to raise awareness
about meningococcal disease in Asia, highlighting the
current knowledge gap.
METHODS
This review attempted to utilize all publicly available
information relevant to the region pertaining to men-
ingococcal disease. A literature search using PubMed
was conducted. The search terms were ‘(meningo-
coccal OR Neisseria meningitidis OR meningitis) AND
Asia’. Secondary searches were performed by replac-
ing ‘Asia’ with one of 20 speciﬁc Asian country names
(China, India, Pakistan, Bangladesh, Sri Lanka, the
Philippines, Japan, Indonesia, Singapore, Malaysia,
Thailand, Taiwan, Vietnam, Cambodia, Laos,
Mongolia,Myanmar,HongKong,RepublicofKorea,
Nepal). The search was limited to human studies. No
restriction on publication year was applied. English-
and non-English-language literature and publications
were assessed for relevance by review of abstracts
when available. Additional references were obtained
by examination of citations in published papers.
Central and regional WHO websites were searched
for outbreak and epidemic information. ProMED
was searched (search term ‘meningitis’) and websites
from local Ministries of Health and Centres for
Disease Control were also accessed. In view of the
incompletenatureofthedata,paperswerenotassessed
usingqualitycriteriabutwereincludediftheyheldany
information on meningococcal disease in the region.
Background to meningococcal disease in the region
A summary of all studies identiﬁed in this review is
provided in Supplementary Tables S1 and S2 (avail-
able online). We found few studies that speciﬁcally
evaluated meningococcal disease epidemiology in
Asia. Most data came from (a) descriptions of out-
breaks(alocalizedclusterofcases)orepidemics(wide-
spread outbreaks of larger magnitude); (b) incidental
detectionofN.meningitidisduringthecourseofstudies
designed to assess the burden of a diﬀerent pathogen:
typically Haemophilus inﬂuenzae type B (Hib) and
Streptococcus pneumoniae;( c) hospital-based pro-
spective and retrospective studies assessing overall
meningitis disease burden, treatment or outcome.
Oﬃcialstatisticswerediﬃculttoobtain.Mandatory
meningococcal surveillance systems appear to operate
only in Japan, Hong Kong, Korea, the Philippines,
Singapore, Thailand and Taiwan, all of which rely on
passive reporting. In Japan only culture-conﬁrmed
cases are required to be notiﬁed. The quality of the
surveillance in these countries was diﬃcult to judge
from the available information. The lack of attention
to the disease may be due to other healthcare issues
and the perception that the disease is rare in much of
Asia [4, 5].
N. meningitidis is fastidious, susceptible to cold
and drying, and culture is frequently unsuccessful.
Antibiotics given prior to cerebrospinal ﬂuid (CSF)
collection signiﬁcantly increase the number of nega-
tive cultures [6, 7]. The technical challenges, as well as
widespread availability of antibiotics (obtained ‘over
the counter’ or by prescription) were identiﬁed by
investigators as hampering attempts to describe
meningococcal disease in Asia [6–9]. Economic con-
straints, lack of after-hours laboratory facilities, lack
of laboratory expertise in detecting N. meningitidis
and lack of available techniques aside from Gram
stain and culture were also identiﬁed as obstacles
to successful N. meningitidis identiﬁcation [10, 11].
Use of polymerase chain reaction (PCR) detection
techniques increases the sensitivity of detection of
N. meningitidis, particularly in patients who have re-
ceived antibiotics [12], but these techniques have been
largely unavailable on a routine basis in much of Asia.
The percentage of CSF or blood samples in which no
bacteria could be identiﬁed was generally high in all
studies we reviewed and appeared to increase over
time, an observation attributed by some authors to
increasing access to antibiotics.
Social and economic obstacles to investigation of
meningococcal disease were also evident. In a retro-
spective hospital review of 435 meningitis cases in
Malaysia, lumbar puncture was performed in only 71
(16.3%) children due to widespread belief in the local
population that lumbar puncture leads to later para-
lysis or impotence [13]. In Pakistan, it is estimated that
only 50% of children with meningitis may reach
hospital [14]. Given all these considerations, it seems
likely that meningococcal infections were under-
diagnosed in the majority of studies we reviewed.
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tially underestimate meningitis cases due to N. men-
ingitidis for the reasons given above, we considered
positive bacteriological identiﬁcation present if an or-
ganism was identiﬁed in CSF or blood culture speci-
mens using any identiﬁcation technique, i.e., Gram
stain,culture,latex agglutination,counter-electropho-
resis or PCR.
THE BURDEN OF DISEASE IN
GAVI-ELIGIBLE COUNTRIES IN ASIA
At the time of writing 11 of the 20 Asian countries we
investigated (India, Pakistan, Bangladesh, Indonesia,
Vietnam, Cambodia, Laos, Mongolia, Myanmar,
Sri Lanka, Nepal), representing a total population
of about 2 million [15], were eligible for funding from
the GAVI Alliance [16]. All 11 countries currently re-
ceive GAVI support. Six of these countries (India,
Indonesia, Mongolia, Nepal, Pakistan, Vietnam) have
suﬀered major serogroup A (or C in Vietnam)
meningococcalepidemics in thelast30 years (Table 1).
Available data suggest that these poorer countries
represent a disproportionately high fraction of the
overall meningococcal disease burden in Asia. The
population incidences of meningococcal disease in
countries with available data are given in Table 2.
Serogroup distributions by country are given in
Figure 1. While some published data were available
for GAVI-eligible countries, these were limited and of
varying quality.
Bangladesh
Many sick children are not brought to hospital and
die at home in Bangladesh [17], suggesting that men-
ingococcal disease cases are likely to be undetected.
Five studies were identiﬁed during this review. Results
from four retrospective hospital-based studies con-
ducted between 1982 and 1994 [49–52], showed
N. meningitidis present in up to 35% (28/79) of posi-
tive cultures in all ages, and up to 18% in children
aged <2 years with bacterial meningitis. In 48 men-
ingococcal-positive CSF specimens between 1987 and
1994 in children aged <5 years, 33 (69%) were from
children aged <12 months [49].
More recently, of 628 blood and CSF samples sent
to the International Centre for Diarrhoeal Disease
Research in Bangladesh between 1999 and 2006,
N. meningitidis was detected in 24.8% (n=136), of
which 97.7% were serogroup A [17]. Almost 60% of
cases occurred in 6- to 24-year-olds, 20.6% occurred
in 25- to 39-year-olds, 7.4% in 1- to 5-year-olds and
2.9% of cases were in children aged <1 year. Between
2002 and 2004 a higher number of samples were pro-
cessed by the laboratory compared to previous years.
Isolation rates of other bacteria did not change over
this time. However, the percentage of N. meningitidis
positive isolates in 2002–2004 was 15 times higher
than in 1999–2000, suggesting that local serogroup A
outbreaks had occurred. The number of N. meningi-
tidis cases then decreased over 2005 and 2006, sug-
gesting that this was not a spurious result linked to
improved detection or awareness.
In 2009 an unpublished outbreak of meningoco-
ccal disease (serogroup unconﬁrmed) was reported
(ProMED) to have spread from India to the
Chittagong Hill Tracts of Bangladesh [53, 54].
Morbidity and mortality data were not retrievable.
India
Epidemic meningococcal disease
India has experienced repeated meningococcal sero-
group A epidemics over the last century [8], most re-
cently in 2005 in Delhi and surrounding districts.
BetweenMarchandJuly2005,444casesand62deaths
[case-fatality rate (CFR) 16.9%] were recorded [55].
The majority of cases (44%) and deaths (62%) were
in adolescents and young adults aged between 15 and
29 years, and 71% of those aﬀected were males [21].
The peak attack rate in Delhi was 13.23/100000 [56].
Serogroup A disease re-appeared in Delhi in between
January and March 2006, with 177 cases reported
(CFR 9.6%) [20].
Other unpublished reports (ProMED) describe sus-
pected meningococcal outbreaks in the regions of
Nawada (2000) [57] and Meghalay, Tripura and
Mizoram (2009, thought to be serogroup A), with
more than 2000 cases and 257 deaths reported in
2008–2009 [54, 58, 59].
Endemic meningococcal disease
The burden of meningococcal disease between out-
breaks in India is diﬃcult to quantify. Studies in non-
outbreak settings performed since 1990 have detected
little meningococcal disease [7, 60–66], but very low
bacterial detection rates in many studies, considered
to be the result of both technical laboratory aspects
and high levels of antibiotic use prior to hospitaliz-
ation (up to 79% in one study [63]), have prevented
ﬁrm conclusions [7, 8]. In a 10-year retrospective
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hospital in Bangalore, N. meningitidis accounted for
only 1.4% of microbiologically proven cases [62]. All
cases occurred in individuals aged >12 years. In
Delhi between the non-epidemic years 2002 and 2004,
971 meningococcal cases with 118 deaths (CFR 12%)
were reported [64].
N. meningitidis serogroup A is most commonly
isolated in India but serogroup B [67] and serogroup
C [68] also play a role in sporadic disease cases.
Indonesia
Six reports were identiﬁed that included a WHO re-
port, and ﬁve studies that described meningitis aeti-
ology or treatment in Indonesia [69–74]. Between
1995 and 1996, N. meningitidis was identiﬁed as the
cause of meningitis in 16.7% (1/6) of bacteriologically
conﬁrmed cases in children aged <5 years [69]. In a
population-based study between 1998 and 2002 of
Hib vaccination in 818 hamlets encompassing 744000
individuals, N. meningitidis was detected in 3/17
(17.6%) culture-positive meningitis cases in children
aged <2 years [70]. In 30/47 (63%) cases of probable
bacterial meningitis the causative organism could not
be identiﬁed, probably due to the high previous anti-
biotic use and technical aspects related to sample
storage [70]. During 2000, 14 cases of meningococcal
meningitis with six deaths (43% mortality) were re-
ported to the WHO in Indonesia [71]. Serogroup B
was detected in one individual.
Mongolia
Five publications were identiﬁed: four described
past epidemics and one was a prospective study of
Table 1. Meningococcal epidemics in Asian countries
Country Year of epidemic Serogroup Cases CFR Rate per 100000 Ref.
Cambodia
China 1984 A 11.7 [18]
1977 A y5% 59 [19]
1967 A* 3 million y6% 150–800 [19]
1959 A* y10% y55 [19]
Hong Kong 1918 — [19]
India 2006 A 177 9.6% [20]
2005 A 426 13.6% 13.23 [21]
1985 A 6133 13% [22]
1966 A* 616 20.9% [22]
Indonesia
Japan
Korea
Laos
Malaysia
Mongolia 1994–95 A 1754 9.3–12.4% 90 (overall) [23]
179 (capital city) [23]
359 (2–18 yr) [23]
1973–74 A or B 704 (<9 yr) [24]
Myanmar
Nepal 1982–84 A 1475 7–9% 103 (overall) [25]
26% 221 (<1 yr) [25]
Pakistan 1988 A 112 11% [26]
Philippines 2004–2005 A 98 33% [27]
Singapore
Sri Lanka
Taiwan 1933–46 A [28]
1919–26 A [28]
Thailand
Vietnam 1977–79 C 27.4–34.7% >20 [29]
CFR, Case-fatality rate.
Shaded areas indicate none reported/no data.
* Serogroup unconﬁrmed.
970 A. Vyse and othersmeningitis aetiology. Large meningococcal serogroup
A epidemics originating in China spread to Mongolia
in 1973–1974 and 1994–1995 [75, 76]. During the
1994–1995 epidemic, the overall attack rate ranged
between 80 and >90/100000, but reached 179/
100000 in the capital city of Ulaanbaator [23]. The
highest incidence was in children aged between 2 and
18 years (attack rate 359/100000) [23]. The fatality
rate was 7–9%, with 122 deaths, and 165 deaths
in the ﬁrst 4 months of 1994 and 1995, respect-
ively [23].
Little is known about the epidemiology of endemic
disease in Mongolia. The estimated incidence rate
during the 1970s non-epidemic period was about
10/100000 population [24]. A prospective hospital-
based study conducted between 2002 and 2005 in
Table 2. Rate of meningococcal disease per 100000 population in countries with available data (non-outbreak
settings)
Country Years studied Age Baseline rate per 100000 Ref.
China 2003–2007 Overall 2.09 (Hefei) [30]
Before 2003 Overall 0.18 (Hefei) [30]
2005 Overall 0.18–0.2 [31]
2000–2002 Overall 0.25 (Nanning) [32]
1989 Overall 1.22 [18]
1988 Overall 1.97 [18]
1987 Overall 3.21 [18]
1986 Overall 7.56 [18]
1985 Overall 10.73 [18]
1984 Overall 11.69 [18]
1983 Overall 7.81 [18]
1982 Overall 8.65 [18]
1981 Overall 13.21 [18]
1980 Overall 23.44 [18]
Hong Kong 1984–1993 f24 m f0.24/13.0* [33]
Japan 1980-current Overall <0.02# [34]
Korea 2004–2008 Overall 0.002–0.017# [35]
2002–2003 Overall 0.06–0.08# [36]
2000–2001 Not speciﬁed
(Army recruits)
2.2 [39]
Mongolia 2002–2005 <5 yr 13 [37]
1971 Overall 17 [24]
Philippines 2004 Overall 0.04 [38]
2005 Overall 0.1 [38]
2006 Overall 0.03 [38]
2007 Overall 0.02 [38]
2008 Overall 0.0 [38]
Singapore 2005–2009 Overall 0.11–0.23# [40]
2000–2001 Not speciﬁed
(Hajj pilgrims)
25 [41]
Taiwan 2001 Overall 0.19 [42, 43]
2000 Overall 0.07 [42]
1991 Overall 0.22 [28]
Thailand 2008 Overall 0.02 [44]
<5y r 0 .10 [44]
2007 Overall 0.05 [44]
<5y r 0 .30 [44]
2000–2001 <5y r 1 .8 [45]
1981–1990 Overall f0.2 [46]
Vietnam Pre-epidemic Overall <5 [29]
2000–2002 <5y r 2 .6 [47]
7–11 mo. 21.8 [47]
* Rate in Chinese and Vietnamese communities respectively.
# Calculated using the UN 2008 Revision Population Database [15] (median variant).
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(23%) of children aged 2 month to 5 years with
conﬁrmed bacterial meningitis, giving a population-
based incidence of 13/100000 [37]. Mortality was
12% [37].
Myanmar
A single brief report from the WHO indicated that
during 1995, 479 cases of meningococcal disease
were reported in Myanmar, with 113 deaths (CFR
24%) [77].
Nepal
Epidemic meningococcal disease was not reported in
Nepal until 1982 when a large meningococcal sero-
group A outbreak occurred in the Kathmandu Valley
with an overall attack rate of 103/100000 [25, 75, 77].
Incidence and mortality was highest in infants
aged <1 year (221/100000 and 26%, respectively).
Incidences in other age groups were 104/100000
(CFR 19%) in the 1–4 years age group, 141–156/
100000 (CFR 6–12%) in the 5–9, 10–14 and 15–19
years age groups, and between 32 and 95/100000
(CFR 5–16%) in adults [25]. After resolution of the
epidemic, meningococcal disease continued to be re-
ported in tourists, primarily hikers, with an attack
rate in 1985 of 19/100000 [78].
Three studies of meningitis aetiology or treatment
were identiﬁed. A single prospective study performed
in a children’s hospital in Kathmandu during 1993
and 1994 showed that N. meningitidis accounted
for 26% (6/23) of pyogenic meningitis cases in those
aged 5 months to 5 years [79]. In two prospective
hospital-based studies between 2001 and 2007,
N. meningitidis accounted for 5.4% (2/37 bacterio-
logically conﬁrmed cases) of bacterial meningitis in all
age groups [80], and 2/151 (1.3%) culture-positive
meningitis cases in the <5 years age group, of whom
26.7% of the 151 individuals had received prior anti-
biotics [81].
Fig. 1. Serogroup distribution of meningococcal disease cases in Asian countries with available data (map outline reproduced
from [48]). %=percentage of serogroupable isolates.
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A meningococcal serogroup A epidemic occurred in
Karachi, Pakistan, in 1988 [26] with 112 cases of
which 20% had septicaemia and 80% had meningo-
coccal meningitis. Children aged between 5 and
10 years were primarily aﬀected. Overall mortality
was 11% but reached 55% in individuals with men-
ingococcaemia.
Bacterial meningitis has been described as a major
health problem in Pakistan [10]. Four studies con-
ducted prior to 2002 suggested that over 30% of
bacterial meningitis in adults and 20% in children
was attributable to N. meningitidis [10, 82–84]. In both
children [82] and adults [10], N. meningitidis was the
second most common cause of bacterial meningitis
afterHibandpneumococcus,respectively.Incontrast,
in a prospective hospital-based study of meningitis in
<5-year-olds conducted between 2005 and 2006,
3.6% (3/83 bacteriologically conﬁrmed cases) were
due to N. meningitidis [85]. Notably, a causal aeti-
ology could not be identiﬁed in 80% of specimens.
The authors noted high rates of prior antibiotic use,
as well as evidence that only 50% of children with
meningitis might reach hospital in Pakistan.
Serogroup data were not available.
Vietnam
A serogroup C epidemic occurred in the southern
provinces of Vietnam between 1977 and 1979 [29, 75].
The overall incidence rate of meningococcal disease
during the epidemic rose from <5/100000 in the pre-
ceding years to >20/100000. The mortality rate was
between 27.4% and 34.7% [29]. Seventy percent of
casesoccurredinchildrenagedbetween3and15years.
Four prospective studies of meningitis have been
conducted since the 1977 epidemic covering the years
1993–2005 [47, 86–88]. Meningococcal disease ac-
counted for 0.5% of positive blood cultures and
around 4–8.5% of bacterial meningitis cases where an
aetiology was identiﬁed. Between 2000 and 2002 the
estimated incidence of meningococcal meningitis in
Hanoi, Vietnam, was 21.8/100000 (95% CI 5.0–94.4)
in children aged 7–11 months and 2.6/100000 in
children aged <5 years (95% CI 0.8–8.5) [47]. Sero-
group data were not available.
Laos, Sri Lanka and Cambodia
We found no information on meningococcal disease
from these countries.
BURDEN OF DISEASE IN NON-GAVI
ELIGIBLE COUNTRIES IN ASIA
Although generally more information was available
for non-GAVI eligible countries, the published data
were still incomplete. Incidence rates have been calcu-
lated where possible. However, systematic present-
ations of epidemiological estimates were not feasible.
China
Epidemic meningococcal disease
Meningococcal disease is endemic in China, and re-
gional or nationwide epidemics have occurred period-
ically over the last century. Much of the published
literature describes these epidemic cycles. In the past
epidemics occurred every 8–10 years, lasting 3–5 years
[89] with the majority of cases occurring between
October and June [90]. During the worst epidemics,
incidence rates of up to 2000/100000 were recorded in
aﬀected unvaccinated communes [91]. In a review of
seasonal variation of meningococcal meningitis inci-
dence rates in Hunan Province, it was noted that be-
tween 1959 and 1990 there were 16 years where the
incidence was <10/100000, 14 years where the overall
disease incidence was between 10 and 99.99/100000,
and 2 years where the incidence was >100/100000
[90]. During the observation period a total of 38148
cases were recorded. The last epidemic in 1984 was
largely attenuated due to widespread use of meningo-
coccal polysaccharide serogroup A vaccine in ado-
lescents and children [92].
Locally produced meningococcal polysaccharide
serogroup A vaccines have been available in China
since the 1950s [93]. Their widespread use since the
1970s has been associated with reductions in the inci-
dence of meningococcal disease, particularly in older
children, as well as loss of epidemic cyclic activity
[89, 90, 93–95]. Prior to vaccination in Zhengzhou,
children aged between 4 and 15 years represented
68.22% of all meningococcal cases, and routine vac-
cination of children aged <15 years began in 1984
and1985[94].Estimatesofeﬃcacyat1yearweremore
than 94% after vaccination in this population [95]. In
1984 in Zhengzhou, meningococcal disease incidence
was 36.35/100000. In 1985 the incidence was 10.08/
100000, decreasing to 0.67/100000 by 1991 [94].
Endemic meningococcal disease
In a survey of bacterial meningitis in children aged
f5 years in Nanning City (Yining County), Guangxi
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N. meningitidis meningitis were observed in 303 clini-
cally conﬁrmed cases of bacterial meningitis out of
a local population of over 141000 children [32].
However, a causative organism was identiﬁed in
only 14% of cases [32]. The regional incidence of
N. meningitidis disease was 0.25/100000 at the time
of the study, attributed to widespread routine use of
serogroup A polysaccharide vaccination. In 2005, the
incidence of meningococcal disease in China was re-
ported to be 0.18–0.2/100000 [31] (Table 2).
Evidence for changing meningococcal serogroup
distribution over time
Historically, meningococcus serogroup A has been
largely responsible for sporadic and epidemic disease
in China. Since the 1980s, the proportion of cases
caused by serogroups B and C has increased [18,
89, 94]. Between 1990 and 1992, 60.9% of 23 men-
ingococcal meningitis cases in children aged f15
years were due to serogroup B and 39.1% to sero-
group A [96].
The ﬁrst recorded serogroup C outbreak in China
was in a village in Guangxi Province during 2002 in
which 3/15 cases died (CFR 20%) [89]. Between 2003
and 2007, serogroup C outbreaks were reported in
Anhui Province [30, 97]. Using data from the Hefei
(capital city of Anhui Province) Center for Disease
Control and Prevention (CDC), the incidence of men-
ingococcal disease in the region was 2.09/100000,
with a greater proportion of cases (60.9%) occurring
in urban regions [30]. In total, 386 cases were reported
in the region of Hefei between 2003 and 2007. Of
135 laboratory-conﬁrmed cases, all were serogroup C.
The age-speciﬁc incidences were 6.57/100000 in the
12–17 years group (1.4% of all cases), 5.55/100000
in those aged <6 years (18.4% of all cases) and
4.71/100000 in the 6–11 years group (18.4% of all
cases). The CFR was 7.3% with the highest CFR in
the 0–5 years age group (16.9%). Implementation of
a serogroup A and C polysaccharide vaccination
programme was not successful [30]. Carriage and
serogrouping studies suggest that serogroup C has
spread through many provinces in China [31, 98]. The
ﬁrst case of serogroup X invasive disease was reported
in Beijing in 2007 [99].
Hong Kong
Epidemic meningococcal disease was reported in
Hong Kong as early as 1918 [19]. No recent epidemics
have occurred. In four hospital-based surveillance
studies conducted between 1984 and 2001, only ﬁve
cases of meningococcal meningitis were reported, all
of which occurred in the Vietnamese minority popu-
lation [33, 100–102]. All aﬀected children were aged
<5 years. All cases were due to serogroup B and one
child died [33]. The incidence rate in the <5-year-old
Vietnamese migrant population in Hong Kong was
estimated to be 13.0/100000 (95% CI 4.2–30.3).
Government data cited in Sung et al. [33] and French
et al. [102] give a meningococcal disease incidence rate
in the overall population of 0.02–0.24/100000 during
the same period. Medical practitioners are required to
notify the Hong Kong Centre for Health Protection
of all suspected and conﬁrmed cases of invasive
meningococcal disease [103]. Notiﬁcations between
2005 and 2009 numbered between 0 and 6 [103]. No
recent serogroup data are available in the literature;
however, a case of serogroup C disease has been
reported [104].
Japan
Historical meningococcal disease burden in Japan
Bacteriologically conﬁrmed meningococcal disease
must be reported to the national register of notiﬁable
diseases in Japan. Records available since before 1920
show between 300 and 1500 meningococcal cases per
year between 1920 and the early 1960s, with a peak in
1945 and around 1947 with about 4500 cases and 3500
cases, respectively [34, 105]. After 1970 the number of
reported cases fell to <100, with fewer than 30 cases
per year reported since 1980 [34, 106, 107]. There
is little seasonal variation in case numbers or mor-
tality [34].
Meningococcal disease in retrospective hospital surveys
Nationwideandlocalretrospectivesurveysofbacterial
meningitis have been performed regularly via ques-
tionnaires sent to medical institutions [105, 107–120].
According to these surveys, the proportion of bac-
terial meningitis cases due to N. meningitidis since
the 1990s has remained below 2%. Since 2000, the
proportion has been less than 1%. Low rates of
meningococcal disease have also been observed in
hospital-based studies [121]. Under-reporting has
been suggested due to problems associated with
handling and laboratory detection of N. meningitidis
and use of antibiotics prior to culture [105, 107, 120].
However, in a study of 168 CSF samples obtained
from patients of all ages throughout Japan from 2005
974 A. Vyse and othersto 2007 that were evaluated using PCR, no N. men-
ingitidis was identiﬁed (0/121 positive samples) [122].
It has been estimated that fewer than 30 cases of men-
ingococcal disease occur per year in Japan [123]
(Table 2), with the majority of cases occurring in
children aged f5 years [34].
A large-scale surveillance study of invasive
meningococcal disease conducted by the Ministry
of Health is currently ongoing [124]. However,
underestimation of the true disease burden is still
considered a possibility, since only culture-proven
meningococcal cases (less likely to be successful when
antibiotics have been administered) are reported to
the health authorities [124].
Meningococcal serogroup distribution
A retrospective survey examined 182 Japanese isolates
collected over 30 years between 1974 and 2004 [125]
using multi-locus sequence typing (MLST). Of these
samples, 49.2% were from patients, 47% were from
nasopharyngeal samples collected from healthy in-
dividuals and 4% were of unknown source. Of the
182 samples, 57% (103) were serogroup B, 21% (39)
were serogroup Y, 1% (1) were W-135 and 21% (39)
were non-groupable. This is in line with oﬃcial data
concluding that although serogroup data is sparse,
serogroup B followed by serogroup Y make up the
majority of meningococcal disease cases in Japan [34].
Three serogroup A cases have been reported in Japan
since 1999. These strains were identical to Chinese
strains and all three individuals had either travelled to
China or had relatives that had travelled there prior
to illness [34]. Only one case of serogroup C disease
has been reported from Tokyo (2003) [34]. The
apparently very low disease incidence is supported
by carriage data suggesting very low population car-
riage prevalence (0.4% prevalence between 2000 and
2002) [126].
Korea
Five publications were identiﬁed. In a review of 140
culture-positive bacterial meningitis cases from 13
hospitals in and around Seoul between 1986 and 1995,
N. meningitidis was the third most common cause of
bacterial meningitis (nine cases, 6.4%) in children
aged <15 years [127], with the highest proportion of
cases in children aged >5 years [127, 128]. In a later,
prospective population-based surveillance of Hib dis-
ease in Korea between 1999 and 2001, no N. meningi-
tidis was isolated in 2176 children evaluated for
possible meningitis [129]. However, a causative
organism was only identiﬁed in 4% of abnormal CSF
samples in this study for reasons that are not clear,
although early use of antibiotic therapy may have
contributed.
In Korean army recruits, the incidence of men-
ingococcal disease was 2.2/100000 (95% CI 1.3–3.8)
in 2000–2001: 1/12 cases was identiﬁed as serogroup
A and three cases were serogroup C [39].
A laboratory-based study of N. meningitidis sero-
groups in Korea, citing Korean Ministry of Health
data, stated that between 1990 and 2001, between 2
and 13 cases of meningococcal disease occurred an-
nually [36]. A substantial increase in disease cases
occurred in 2002 (27 cases) and 2003 (38 cases) [36].
Of nine clinical isolates from across Korea during
these 2 years, seven were serogroup Y, with one each
being serogroups B and 29E, suggesting locally
evolving meningococcal epidemiology. Since 2003,
the number of N. meningitidis cases notiﬁed to the
Korean CDC was eight in 2004, seven in 2005, 11 in
2006, four in 2007 and one in 2008 [35] (Table 2).
Malaysia
Four retrospective reviews from hospitals in various
regions within Malaysia have been published [5, 13,
130, 131]. The most recent of these reviewed micro-
biologically conﬁrmed meningococcal disease occurr-
ing between 1987 and 2004 in a large university
hospital in Kuala Lumpur [5]. Only 17 cases (12 with
data) were noted during the observation period. Seven
cases occurred in the 20–35 years age group, three
cases in the 10–15 years group and one case in a child
aged 10 months. Mortality was 25%. Of six cases
where the serogroup was identiﬁed, one case was
identiﬁed as serogroup B and ﬁve cases as serogroup
W-135. These data contrast with other earlier studies
that suggest a signiﬁcant burden of disease due to
N. meningitidis, including infants aged <1 year [130].
The low detection rate in later studies may be due in
part to low acceptance of lumbar puncture [13] and/or
because some cases might go unrecognized.
An outbreak of suspected meningococcal disease
was reported (ProMED) in trainees of the Road
Transport Department (JPJ) Academy in Malacca in
2009, with 20 cases and one death [132].
The Philippines
Available information sources included ﬁve publica-
tions, a report from the WHO and annual reports
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17 and 35 cases of meningococcal disease were re-
ported annually to the Department of Health between
2004 and 2008, with the exception of 2005 when 115
cases were reported [38]. This increase was due to a
meningococcal serogroup A outbreak that occurred
in the regions of Baguio City, Mt Province and Ifuga
in the Philippines in 2004 and 2005, with 98 cases
(33% mortality) reported to the WHO up to January
2005 [27]. The incidence per population in the non-
outbreak years ranged between 0.0 and 0.04/100000
(Table 2) but there was marked variability between
regions [38]. In non-outbreak years between 34%
and 50% of cases were reported in children aged
<5 years. In 2005 most cases (88/115) were reported
in the 5–49 years age group [38].
An outbreak of meningococcal disease, probably
due to serogroup A, of 10 cases (incidence 65/100000
population) was reported in 1989 in San Jose,
Sipalay, Negros Occidental [133]. All but one case had
meningococcaemia and mortality was 50%. Seven
of 10 cases occurred in individuals aged f19 years
[133].
Threeprospectivehospital-basedstudiesinchildren,
carried out between 1991 and 2000, failed to identify
N. meningitidis in Filipino children with serious infec-
tions including meningitis [134–136]. Notably, in two
of these studies, culture was successful in only around
8% of cases [134, 136]. Earlier retrospective hospital-
based studies conducted during the 1980s detected
N. meningitidis in up to 16.7% of children aged <15
years with meningitis, with most cases occurring in
children aged <5 years [137, 138].
Singapore
The number of invasive meningococcal disease cases
reported to the Singapore Ministry of Health over the
last 5 years was ﬁve in 2009, six in 2008, ﬁve in 2007,
ten in 2006 and ﬁve in 2005 [40] (Table 2). Estimations
of the proportion of meningitis cases caused by
N. meningitidis have been made in adults and children
in ﬁve retrospective hospital-based studies carried out
between 1975 and 2000 [139–144]. In studies with
available data, the proportion of culture-negative
meningitis cases was high (between 30% and 55%)
and in one study [139], 55% of subjects had received
antibiotics prior to admission to hospital. In
adults, N. meningitidis was present in up to 20% of
community-acquired cases of bacterial meningitis
[139]. In children, N. meningitidis accounted for
between 0% and 12.5% of cases, with decreasing
frequency over time from the 1970s to the 1990s.
Little data about prevailing serogroups are avail-
able. Cases of meningococcal disease identiﬁed be-
tween 1975 and 1979 were a result of serogroups X, Y
or Z [144]. Between 1981 and 2000, 66 cases of men-
ingococcal disease were described [140]. The age of
the patients ranged from 3 weeks to 81 years; 28/58
serogroupable strains were serogroup B (53%),
10 (18%) serogroup C and nine (16%) serogroup
W-135. Mortality was 22.7%.
Disease due to serogroup W-135 was not detected
in Singapore prior to 2000 but has since been
observed, mainly aﬀecting Hajj pilgrims and their
contacts [41]. Twelve cases of serogroup W-135 men-
ingitis were documented in Singapore between 2000
and 2001 (age range 1–75 years), eight of whom were
Hajj pilgrims or their contacts [41, 145, 146]. There
was one death and the attack rate for serogroup
W-135 disease in Singaporee Hajj pilgrims was esti-
mated at 25/100000.
Taiwan
N. meningitis as a cause of all bacterial meningitis
Prospective [147, 148] and retrospective [149–156]
hospital-based studies conducted between 1981 and
2005 show N. meningitidis to be a relatively uncom-
mon cause of bacterial meningitis in all age groups.
N. meningitidis was responsible for between 0% and
2.5% of meningitis cases in adults (with the exception
of one study showing 6% [155]), and 3.5–4.95% of
cases in children aged <15 years. Nevertheless, in one
prospective study, N. meningitidis was the third most
common cause of meningitis in children aged
>2 months [147].
N. meningitidis occurrence and changing incidence
over time
Epidemics of serogroup A meningococcal disease
occurred in Taiwan between 1919 and 1926, and 1933
and 1946 [28] with about 300 cases reported in each
outbreak year. Meningococcal disease has been noti-
ﬁed to the Taiwan CDC since the 1950s [157].
Between 1950 and 2001, 659 meningococcal cases
were reported with peaks in 1953 (incidence rate 0.94/
100000) and 1959 (0.52/100000), dropping to very
low levels over the ensuing decades [157]. In 1991 the
incidence of meningococcal disease was estimated by
the CDC to be 0.22/100000, with the highest rate in
976 A. Vyse and others20- to 24-year-olds (0.38–0.71/100000 according to
region [158]) (Table 2). Prior to 2001, between 17 and
34 meningococcal disease cases were reported each
year [43] and in 2000 the incidence rate in Taiwan was
estimated to be 0.07/100000 [41]. The mean age was
19.4 years, 33.6% were aged between 11 and 30 years
and 31.3% were <1 year old.
In 2001 and 2002, changes in the epidemiology of
meningococcal disease in Taiwan were observed in
terms of incidence, serogroup distribution and poss-
ibly the age distribution of cases. The overall inci-
dence more than doubled in 2001 (0.19/100000) [41,
43] with an overall mortality of 25.6% [157]. Cases
were geographically dispersed and none had travelled
to the Hajj or had contact with Hajj pilgrims [157].
The age distribution of 115 cases collected between
2001 and 2003 was: <1 year, 27 cases (23.5%); 1–9
years, 16 cases (13.9%); 10–19 years, 16 cases
(13.9%); 20–54 years, 37 cases (32.2%); o55 years,
19 cases (16.5%) [41].
In recent years the incidence of meningococcal dis-
easecasesappearstohavegonebacktolevelsobserved
prior to 2001–2002. The number of meningococcal
disease cases reported to the Taiwan CDC from 2006
was 13 in 2006, 20 in 2007, 19 in 2008, two in 2009 and
one case to date in 2010 [159].
Evidence for changing meningococcal serogroup
distribution over time
Serogroups B and W-135 predominated in Taiwan
prior to 2001 [43, 160, 161]. Serogroup B was re-
sponsible for 48.8% of meningococcal cases between
1995 and 1999 [160] and for 84.6% (11/13) in 1999
[43]. Concurrent with an increase in disease incidence
in 2001 and 2002 has been an apparent change in the
serogroup distribution of cases. Of 115 conﬁrmed
cases collected between 2001 and 2003, 55 (47.8%)
were serogroup B, 30 (26.1%) were serogroup W-135,
17 (14.8%) were serogroup Y, six (5.2%) were non-
groupable, four (3.5%) were serogroup C and three
(2.6%) were serogroup A [41]. Serogroup Y appeared
for the ﬁrst time in 2001, and cases of disease due to
serogroups A and C also started to emerge at this time
[43, 157]. These serogroups A, C and Y meningo-
coccal strains were identiﬁed as worldwide epidemic
clones [43].
Thailand
Between1981and1990theincidenceofmeningococcal
disease was cited as 0.03–0.2/100000 population
by government sources (Annual Epidemiology
Surveillance Report 1990 cited in [46]). In 2007 and
2008 the incidence rates were unchanged, with 30 and
15 meningococcal disease cases reported tothe Bureau
of Epidemiology, respectively (incidence of 0.02–0.05/
100000 population) [44]. The highest incidence
was observed in children aged <5 years (0.1x0.3/
100000), and case fatality was 33.3% in 2007 and
13.33% in 2008. Most notiﬁcations came from re-
gions in the south. No seasonality was observed and
serogroup B was the only serogroup identiﬁed [44].
Retrospective hospital-based studies have also
detected few meningococcal disease cases [4, 11, 46,
162–165]. Of 36 culture-positive meningococcal cases
observed in 13 government hospitals throughout
Thailand between 1994 and 1999, 22/36 (61.1%) cases
occurred in children aged <15 years, with a peak in
children aged <5 years. Of 16 serogrouped isolates,
serogroup B was most frequently represented (9/16);
serogroup A was identiﬁed in two cases and sero-
groups C and W-135 in one case each. A meningo-
coccal carriage study between 1983 and 1984 showed
that 14.23% of children aged between 5 and 15 years
were nasopharyngeal carriers of N. meningitidis.
The authors postulated that the apparently very low
incidence of meningococcal disease in Thailand was
spurious, due to over-the-counter availability of anti-
biotics and technical problems in laboratories such as
lack of after-hours facilities [11]. Corroborating this
hypothesis, a well conducted prospective population-
based survey of bacterial meningitis in two northern
provinces (Lampang, Phitsanulok) of Thailand be-
tween 2000 and 2001 estimated a rate of meningo-
coccal meningitis that was tenfold higher in children
aged <5 years (1.8/100000) [45]. In this study, health
workers and laboratory staﬀ were trained and lab-
oratory methods optimized. Lumbar puncture was
performed in 76.1% of 598 enrolled children and
94.3% of samples were tested by PCR, including
testing for N. meningitidis.
SUMMARY
Data describing the epidemiology of meningococcal
disease in Asia are incomplete. Yet it is apparent that
the burden of disease due to N. meningitidis, and
prevailing serogroups, are highly heterogenous across
Asia. This is not surprising given variations across the
region in climate (from temperate to tropical to dry
desert), socio-demography (with overcrowding in
some regions and variable access to health care
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of developed and developing countries), and religious
practices (including a substantial Muslim population
in some countries that attend Hajj, which is associated
with meningococcal disease outbreaks). All of these
factors can inﬂuence meningococcal disease epidemi-
ology, as well as the ability to detect and treat cases
and implement surveillance.
Widespread devastating meningococcal serogroup
A epidemics have occurred in China, Hong Kong,
India, Mongolia, Nepal, Pakistan, the Philippines and
Taiwan over the last century. Since 1980, six sero-
group A epidemics have been reported in Asian
countries, including India (two epidemics, most re-
cently in 2005), Mongolia, Nepal, Pakistan and the
Philippines (also in 2005). Almost 10000 cases of
epidemic meningococcal disease have been reported
during these epidemics. Reported epidemic mortality
ranged between 7% and 33%. More recently, other
serogroups have been responsible for local outbreaks
in China (serogroup C [30]), Singapore (serogroup
W-135 [41]) and Taiwan (serogroup Y [43]). Although
some countries (Thailand, Malaysia, Indonesia) re-
quire vaccination of Hajj pilgrims against meningo-
coccal disease with tetravalent ACWY polysaccharide
vaccines, we found evidence of routine mass men-
ingococcal vaccination only in China [166]. Polysac-
charide serogroup A vaccines were used for outbreak/
epidemic control during the late 1970s and 1980s.
Sincethe1980s,vaccinationofchildrenwithtwodoses
of serogroup A vaccine between 6 and 18 months of
age, and vaccination with serogroup A and C vaccine
at 3 and 6 years of age is recommended [165]. Cover-
age is reported to be very high [167]. In Korea, the
Korean Paediatric Society recommends meningo-
coccal vaccination for high-risk groups (asplenia,
complement deﬁciency, travellers to endemic areas)
[168], although no meningococcal polysaccharide
or conjugate vaccine is currently available. No
meningococcal conjugate vaccines are currently
routinely recommended in any of the other countries
we studied in this review.
Endemic meningococcal disease epidemiology is
even less well described across Asia. In individual
studies N. meningitidis was one of the three most
common causes of meningitis in children in India
[169], Korea [127], Pakistan [82] and Taiwan [147] and
in adults in India [170] and Pakistan [10]. Ready
access to antibiotics and laboratory-related technical
issues have clearly inﬂuenced N. meningitidis detec-
tion rates in Asia. Widespread availability and use of
more precise tools such as PCR, as well as the estab-
lishment of ongoing surveillance systems, are needed
to improve disease ascertainment in many countries.
Incountrieswithavailablehistoricaltimeseriesdata
(India, China, Japan, Korea, Singapore, Taiwan), the
contribution of N. meningitidis to childhood and adult
meningitis has apparently fallen to very low levels
per 100000 population over the last century (Table 2).
In China this has been largely attributed to widely
implemented polysaccharide vaccine immunisation
programmes. In other countries the reason for the
reduction in cases is less clear, but may be linked to
improving socio-economic conditions, although simi-
lar variability in Hib and pneumococcal disease across
Asia has been observed [171, 172]. Understanding the
reasons behind this apparently very low disease inci-
dence in these countries remains an epidemiological
challenge and is an important topic of future epide-
miological research. These apparent reductions are
in marked contrast to the situation in developing
GAVI-eligible countries where the available data sug-
gest an important, ongoing meningococcal disease
burden aﬀecting children and adults. The disease
burden appears both epidemic and endemic, but re-
mains poorly described.
Available estimates for meningococcal disease in
developed countries in the 21st century are no more
than 2.6/100000 population in any country, although
higher rates are observed in some speciﬁc groups,
such as the Vietnamese immigrant community in
Hong Kong and Hajj pilgrims in Singapore (Table 2).
Notably, disease incidence estimates were not avail-
able for 12 of the 20 countries we studied, including
9/11 GAVI-eligible countries. Based on the limited
available evidence, population disease incidence rates
in GAVI-eligible countries are expected to be higher
than those in industrialized countries within Asia.
In 1997 the WHO estimated that 160000 cases of
meningitis occurred in South East Asia, of which
55000 were due to non-epidemic meningococcal dis-
ease [173].
The available serogroup data indicate that all of the
ﬁve major disease-causing meningococcal serogroups
are present in Asia, albeit with wide variability in their
distribution across the region. Serogroup A domi-
nates in Bangladesh, and in China and India during
epidemic years, while serogroups B and C are present
in sporadic cases, with evidence of more serogroup B
and C disease in China since the 1980s [18, 89, 94].
Serogroup B is most commonly implicated as a cause
of sporadic disease in Japan, Singapore, Thailand and
978 A. Vyse and othersTaiwan, and is present in Malaysia, Mongolia and
Indonesia. Important contributions to disease are
made by serogroup Y in Japan and Taiwan, sero-
group C in Singapore and serogroup W-135 in
Singapore and Taiwan.
We found evidence of evolving meningococcal
disease epidemiology in Mongolia, Nepal, China,
India, Korea, Japan, Singapore and Taiwan, with
strain importation clearly implicated in some coun-
tries. Epidemics of serogroup A disease were ﬁrst
described relatively recently in Mongolia [77] and
Nepal [61] in the 1970s and 1980s. In China and India
where serogroup A has historically dominated, there
is some evidence that serogroup B meningitis has
subsequently emerged [67, 96]. Additionally, sero-
group C has become established in some regions of
China since 2002 [30]. In Japan, serogroup A was ﬁrst
identiﬁed in 1999 and was probably imported from
China, while the ﬁrst serogroup C case was identiﬁed
in 2003 [34]. In Taiwan, serogroups A, C and Y have
been observed since 2000 [43]. In Singapore, sero-
group W-135 appeared for the ﬁrst time in 2000 in
Hajj pilgrims and their contacts [41]. The large Asian
Muslim population points to an ongoing risk of fu-
ture Hajj-related outbreaks. Circulation of multiple
serogroups, as well as evidence of changing serogroup
distribution, argue for use of meningococcal vaccines
giving broad coverage, such as tetravalent ACWY
conjugates, in many countries in Asia. Furthermore,
broad coverage by tetravalent vaccines may be the
vaccination strategy of choice in those countries as yet
without routine surveillance and precise serogroup
information.
The absence of high-quality disease surveillance
systems among many countries in Asia is likely to
contribute to delays in making informed decisions
about the potential beneﬁts of introducing vacci-
nation programmes. This has been the case for both
Hib and S. pneumoniae, where implementation of
universal mass vaccination has been slow in Asian
countries due to lack of epidemiological data [172,
174]. This review has highlighted problems that are
manifested across most of the region for detecting
cases of meningococcal disease. As observed for
studies describing the burden of Hib and pneumo-
coccal disease in Asia, under-detection is a major
problem due to high levels of prior antibiotic use and
suboptimal procedures associated with sample hand-
ling and laboratory testing in some countries [172,
174]. Access to more sensitive molecular technologies
such as PCR is needed, and country-speciﬁc issues
such as fears surrounding lumbar puncture, and lack
of access to hospital care for many sick children, will
also need to be overcome in order to more accurately
assess the true disease burden. A further problem is
that the ability to apply standardized meningococcal
case deﬁnitions such as those advocated by WHO
[175] will diﬀer regionally, with clinical diagnoses
most likely in rural areas and case conﬁrmation only
possible in areas with well-equipped laboratories
[3, 175].
There is currently only limited information avail-
able to assess the burden of meningococcal disease in
much of developing Asia, and it is likely to be under-
recognised. Therefore, there is a need for introducing
and improving surveillance capacity across the region
tomoreaccuratelyassessthediseaseburdenanddeter-
mine serogroup distribution. Meningococcal sero-
group A outbreaks represent an ongoing threat, and
importation of previously unseen serogroups poses a
continuing potential epidemic risk in Asia. Mulitval-
ent meningococcal conjugate vaccines targeting the
major disease-causing serogroups (e.g. A, C, W-135
and Y conjugate vaccines that are now available),
particularly if licensed for use in younger children,
may oﬀer opportunities for disease control in the
region. There may also be a role for a serogroup B
vaccine in the region once one becomes available that
can provide broad protection against serogroup B
disease.
NOTE
Supplementary material accompanies this paper on
the Journal’s website (http://journals.cambridge.org/
hyg).
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